Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 10 Neoplasms 7 Anxiety Disorders 6 Head and Neck Neoplasms 3 Depression 3 Ovarian Neoplasms 2 Hot Flashes 2 Chronic Pain 2 Xerostomia 1 Vomiting 1 Uterine Cervical Neoplasms 1 Testicular Germ Cell Tumor 1 Tendinopathy 1 Smoking Cessation 1 Sleep Wake Disorders 1 Sarcoma 1 Radiculopathy 1 Pulmonary Disease, Chronic Obstructive 1 Prostatic Neoplasms 1 Pathophobia 1 Pain, Postoperative 1 Pain 1 Nociceptive Pain 1 Neuralgia, Postherpetic 1 Neuralgia 1 Nausea 1 Myocarditis 1 Musculoskeletal Pain 1 Melanoma 1 Medication Adherence 1

Interventions

Bevacizumab 19 Capecitabine 15 Oxaliplatin 11 Irinotecan 11 Cetuximab 11 Fluorouracil 10 Leucovorin 8 aflibercept 7 Panitumumab 6 trifluridine tipiracil drug combination 4 Nivolumab 4 sintilimab 3 regorafenib 3 Ipilimumab 3 Vemurafenib 2 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2 HMPL-013 2 Folfox protocol 2 Drug Therapy 2 tremelimumab 1 spartalizumab 1 raltitrexed 1 pembrolizumab 1 monoclonal antibody YYB-101 1 masitinib 1 irinotecan sucrosofate 1 glucopyranosyl lipid-A 1 folfirinox 1 durvalumab 1 camrelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Cancer Metastatic × Hypnosis × Clear all

NCT04999306 2025-02-13

COLOFIGHT

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Terminated

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡